
KR
Composition Comprising the Extracts of Dictyota coriaceum for Prevention and Treatment of Cardiovascular Dyscrasia
10-0834348 (YJC)
KR
Composition Comprising the Extracts of Lysimachia Clethroides for Prevention and Treatment of Cardiovascular Diseases
10-0948332 (YJC/HWP)
KR
Manufacturing Process of Gel Including L-ornithine-L-aspartate and Gel thereof
10-0948332 (YJC/HWP)
KR
Composition Comprising the Extracts of Lindera Obtusiloba for Prevention and Treatment of
10-0989093 (YJC/HWP)
KR
Cardiovascular Diseases 3-Aminopyrrolidine Derivatives as CCR2 Antagonists
2008-0134124 (YJC)
KR
Piperazinylethyl 3-aminopyrrolidine Derivatives as CCR2 Antagonists
2009-0063136 (YJC)
KR
Composition Comprising the Extracts of Lindera obtusiloba as Effective Ingredient for Prevention and Treatment of
2009-0112484 (YJC/HWP)
KR
Thrombosis Method for Preparing and Purifying of Glyceryl Monooleate
2010-0031990 (YJC)
KR
Pharmaceutical Compositions Comprising Anti-asthmatic 3-Aminopyrrolidine Derivatives
2010-0098495 (YJC)
PCT
Composition Comprising the Extracts of Lindera Obtusiloba for Prevention and Treatment of Cardiovascular Diseases
PCT/Kr2008/007484 (YJC/HWP)
PCT
Composition Comprising the Extracts of Lindera Obtusiloba for Prevention and Treatment of Cardiovascular Diseases
PCT/Kr2008/007485 (YJC/HWP)
PCT
3-Aminopyrrolidine Derivatives as CCR2 Antagonists
PCT/Kr2009/006854 (YJC)
PCT
Piperazinylethyl 3-aminopyrrolidine Derivatives as CCR2 Antagonists
PCT/Kr2010/007485 (YJC)
PCT
Tablet-type Compositions of Sweetener and Production Method thereof
PCT/Kr2011/0008317 (YJC)
Composition Comprising the Extracts of Dictyota coriaceum for Prevention and Treatment of Cardiovascular Dyscrasia
10-0834348 (YJC)
KR
Composition Comprising the Extracts of Lysimachia Clethroides for Prevention and Treatment of Cardiovascular Diseases
10-0948332 (YJC/HWP)
KR
Manufacturing Process of Gel Including L-ornithine-L-aspartate and Gel thereof
10-0948332 (YJC/HWP)
KR
Composition Comprising the Extracts of Lindera Obtusiloba for Prevention and Treatment of
10-0989093 (YJC/HWP)
KR
Cardiovascular Diseases 3-Aminopyrrolidine Derivatives as CCR2 Antagonists
2008-0134124 (YJC)
KR
Piperazinylethyl 3-aminopyrrolidine Derivatives as CCR2 Antagonists
2009-0063136 (YJC)
KR
Composition Comprising the Extracts of Lindera obtusiloba as Effective Ingredient for Prevention and Treatment of
2009-0112484 (YJC/HWP)
KR
Thrombosis Method for Preparing and Purifying of Glyceryl Monooleate
2010-0031990 (YJC)
KR
Pharmaceutical Compositions Comprising Anti-asthmatic 3-Aminopyrrolidine Derivatives
2010-0098495 (YJC)
PCT
Composition Comprising the Extracts of Lindera Obtusiloba for Prevention and Treatment of Cardiovascular Diseases
PCT/Kr2008/007484 (YJC/HWP)
PCT
Composition Comprising the Extracts of Lindera Obtusiloba for Prevention and Treatment of Cardiovascular Diseases
PCT/Kr2008/007485 (YJC/HWP)
PCT
3-Aminopyrrolidine Derivatives as CCR2 Antagonists
PCT/Kr2009/006854 (YJC)
PCT
Piperazinylethyl 3-aminopyrrolidine Derivatives as CCR2 Antagonists
PCT/Kr2010/007485 (YJC)
PCT
Tablet-type Compositions of Sweetener and Production Method thereof
PCT/Kr2011/0008317 (YJC)

Lim JW, Oh Y, Kim JH, Oak MH, Na Y, Lee JO, Lee SW, Cho H, Park WK, Choi G, Kang J. Synthesis and biological evaluation of 3-aminopyrrolidine
derivatives as CC chemokine receptor 2 antagonists.
Bioorg Med Chem Left 2012;20;2099-2102.
Lim JW, Na Y, Oak MH, Kim JH, Oh Y, Lee SW, Cho H, Park WK, Choi G, Kim KR, Kang J, Synthesis and biological evaluation of 1-cyclohexyl substituted 3-aminopyrrodine derivatives as CC chemokine receptor 2 antagonists.
Bull Korean Chem Soc. 20120;31;1827-1828
Kim JH, Lim JW, Lee SW, Kim KR, No KT. Ligand supported homology modeling and docking evaluation of CCR2: docked pose selection by consensus scoring.
J Mol Model 2011; 17; 2707-2716.
Lee JO, Park DH, Jung HS, Lee SW, Oak MH. The antithrombotic activity of ethanol extract of lysimachia clethroides.
J Korean Soc Appl Biol Chem 2012;53(3);384-387.
Lee JO, Kim CY, Lee SW, Oak MH. Antiplatelet and antithrombotic activity of lindera obtusiloba extract in vitro and in vivo.
Biomolecules & Therapeutics 2012;18(2);205-210
Bioorg Med Chem Left 2012;20;2099-2102.
Lim JW, Na Y, Oak MH, Kim JH, Oh Y, Lee SW, Cho H, Park WK, Choi G, Kim KR, Kang J, Synthesis and biological evaluation of 1-cyclohexyl substituted 3-aminopyrrodine derivatives as CC chemokine receptor 2 antagonists.
Bull Korean Chem Soc. 20120;31;1827-1828
Kim JH, Lim JW, Lee SW, Kim KR, No KT. Ligand supported homology modeling and docking evaluation of CCR2: docked pose selection by consensus scoring.
J Mol Model 2011; 17; 2707-2716.
Lee JO, Park DH, Jung HS, Lee SW, Oak MH. The antithrombotic activity of ethanol extract of lysimachia clethroides.
J Korean Soc Appl Biol Chem 2012;53(3);384-387.
Lee JO, Kim CY, Lee SW, Oak MH. Antiplatelet and antithrombotic activity of lindera obtusiloba extract in vitro and in vivo.
Biomolecules & Therapeutics 2012;18(2);205-210